C07K 16/118
Hepatitis c virus
Official title: Hepatitis C virus; GB virus C [GBV-C]
C07K16/118 (Hepatitis c virus) appears on 177 US grants and 199 published applications in this corpus.
Search patents in C07K- Granted patents
- 177
- Published applications
- 199
- Assignees
- 131
- Inventors
- 411
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 8 | 0 |
| 1998 | 11 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 4 | 0 |
| 2002 | 2 | 10 |
| 2003 | 6 | 15 |
| 2004 | 6 | 12 |
| 2005 | 9 | 6 |
| 2006 | 8 | 13 |
| 2007 | 7 | 10 |
| 2008 | 6 | 9 |
| 2009 | 3 | 12 |
| 2010 | 7 | 8 |
| 2011 | 2 | 11 |
| 2012 | 3 | 8 |
| 2013 | 8 | 9 |
| 2014 | 10 | 11 |
| 2015 | 6 | 13 |
| 2016 | 10 | 5 |
| 2017 | 5 | 9 |
| 2018 | 3 | 4 |
| 2019 | 9 | 9 |
| 2020 | 3 | 3 |
| 2021 | 2 | 4 |
| 2022 | 2 | 8 |
| 2023 | 4 | 2 |
| 2024 | 4 | 4 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- HIV/HCV cross-reactive antibodies and uses thereof12 May 2026US 12,624,091 B2Vanderbilt University
- Method of treating HBV infection by using anti-pre-S1 HBV antibodies30 Dec 2025US 12,509,504 B2Huahui Health Ltd.
- Method for preparing multimeric forms of the hepatitis c virus (HCV) envelope glycoprotein 2 (HCV E2)10 Dec 2024US 12,162,906 B2Macfarlane Burnet Institute for Medical Research and Public Health Limited
- Chimeric antigen receptor-modified NK-92 cells8 Oct 2024US 12,109,238 B2ImmunityBio, Inc.
- Immunoglobulins directed to bacterial, viral and endogenous polypetides27 Aug 2024US 12,071,471 B2Covalent Bioscience Incorporated
- Human broadly neutralizing monoclonal antibodies associated with hepatitisc virus clearance10 Sep 2026US 2026/0265351 A1The Johns Hopkins University
- Hcv antigens and antibodies19 Mar 2026US 2026/0078172 A1The Johns Hopkins University
- Engineered polypeptides25 Sep 2025US 2025/0296986 A1Vir Biotechnology, Inc.
- Assembled glycoproteins3 Jul 2025US 2025/0215048 A1Macfarlane Burnet Institute for Medical Research and Public Health Limited
- Chimeric Antigen Receptor-Modified NK-92 Cells7 Nov 2024US 2024/0366972 A1ImmunityBio, Inc.
Most cited
By later US patents
- HCV immunoassays employing C domain antigens147US 5,350,671 AChiron Corporation · 1994
- Gas inlet for a plurality of reactant gases into reaction vessel142US 5,441,703 AAixtron SE · 1995
- Retro-, inverso- and retro-inverso synthetic peptide analogues90US 6,261,569 B1Deakin Research Limited · 2001
- Synthetic peptides specific for the detection of antibodies to HCV73US 5,106,726 AUnited Biomedical, Inc. · 1992
- Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies71US 5,683,864 AChiron Corporation · 1997